Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

En global fase III-studie av Rilvegostomig eller pembrolizumab monoterapi for førstelinjebehandling av PD-L1-høy metastatisk ikke-småcellet lungekreft (ARTEMIDELung04)

24. september 2026 oppdatert av: AstraZeneca

En fase III, randomisert, dobbeltblind, multisenter, global studie av Rilvegostomig eller pembrolizumab monoterapi for første linjebehandling av pasienter med PD-L1-høy metastatisk ikke-småcellet lungekreft (Artemide-Lung04)

The purpose of ARTEMIDE-Lung04 is to assess the efficacy and safety of rilvegostomig compared with pembrolizumab monotherapy as 1L treatment in participants with mNSCLC and whose tumors express PD-L1.

Studieoversikt

Detaljert beskrivelse

This is a Phase III, two-arm, randomized, double-blind, global, multicenter study assessing the efficacy and safety of rilvegostomig compared to pembrolizumab as a 1L treatment for patients with mNSCLC whose tumors express PD-L1.

Studietype

Intervensjonell

Registrering (Antatt)

830

Fase

  • Fase 3

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

      • CABA, Argentina, 1425
        • Rekruttering
        • Research Site
      • Córdoba, Argentina, 5000
        • Rekruttering
        • Research Site
      • Pilar, Argentina, B1629AHJ
        • Rekruttering
        • Research Site
      • Rosario, Argentina, S2000CVB
        • Rekruttering
        • Research Site
      • Rosario, Argentina, 2000
        • Rekruttering
        • Research Site
      • Viedma, Argentina, R8500ACE
        • Rekruttering
        • Research Site
      • Hobart, Australia, 7000
        • Tilbaketrukket
        • Research Site
      • Woolloongabba, Australia, 4102
        • Tilbaketrukket
        • Research Site
      • Edegem, Belgia, 2650
        • Rekruttering
        • Research Site
      • Jette, Belgia, 1090
        • Rekruttering
        • Research Site
      • Libramont-Chevigny, Belgia, 6800
        • Rekruttering
        • Research Site
      • Liège, Belgia, 4000
        • Rekruttering
        • Research Site
      • Mechelen, Belgia, 2800
        • Rekruttering
        • Research Site
      • Roeselaere, Belgia, 8800
        • Rekruttering
        • Research Site
      • Blumenau, Brasil, 89010-340
        • Rekruttering
        • Research Site
      • Fortaleza, Brasil, 60336-550
        • Rekruttering
        • Research Site
      • Ijuí, Brasil, 98700-000
        • Rekruttering
        • Research Site
      • Itajaí, Brasil, 88301-220
        • Rekruttering
        • Research Site
      • Londrina, Brasil, 86015-520
        • Rekruttering
        • Research Site
      • Passo Fundo, Brasil, 99010-260
        • Rekruttering
        • Research Site
      • Porto Alegre, Brasil, 90035-903
        • Rekruttering
        • Research Site
      • Porto Alegre, Brasil, 90610-000
        • Rekruttering
        • Research Site
      • Porto Velho, Brasil, 76834-899
        • Rekruttering
        • Research Site
      • Salvador, Brasil, 41950-640
        • Rekruttering
        • Research Site
      • Salvador, Brasil, 41253-190
        • Rekruttering
        • Research Site
      • Santo André, Brasil, 09060-650
        • Rekruttering
        • Research Site
      • São Paulo, Brasil, 01246-000
        • Rekruttering
        • Research Site
      • São Paulo, Brasil, 04501-000
        • Rekruttering
        • Research Site
      • Teresina, Brasil, 64049-200
        • Rekruttering
        • Research Site
      • Burgas, Bulgaria, 8000
        • Rekruttering
        • Research Site
      • Panagyurishte, Bulgaria, 4500
        • Rekruttering
        • Research Site
      • Sofia, Bulgaria, 1407
        • Rekruttering
        • Research Site
      • Sofia, Bulgaria, 1756
        • Rekruttering
        • Research Site
      • Sofia, Bulgaria, 1618
        • Rekruttering
        • Research Site
      • Varna, Bulgaria, 9010
        • Har ikke rekruttert ennå
        • Research Site
    • Alberta
      • Edmonton, Alberta, Canada, T6G 1Z2
        • Rekruttering
        • Research Site
    • British Columbia
      • Kelowna, British Columbia, Canada, V1Y 5L3
        • Har ikke rekruttert ennå
        • Research Site
    • Ontario
      • Cambridge, Ontario, Canada, N1R 3G2
        • Har ikke rekruttert ennå
        • Research Site
      • Newmarket, Ontario, Canada, L3Y 2P9
        • Har ikke rekruttert ennå
        • Research Site
      • Toronto, Ontario, Canada, M4N 3M5
        • Rekruttering
        • Research Site
    • Quebec
      • Québec, Quebec, Canada, G1V 4G5
        • Har ikke rekruttert ennå
        • Research Site
      • Saint-Jérôme, Quebec, Canada, J7Z 5T3
        • Har ikke rekruttert ennå
        • Research Site
      • Conception, Chile, 4070196
        • Rekruttering
        • Research Site
      • Santiago, Chile, 7500653
        • Rekruttering
        • Research Site
      • Santiago, Chile, 8420383
        • Rekruttering
        • Research Site
      • Santiago, Chile, 7500713
        • Rekruttering
        • Research Site
      • Cali, Colombia, 760032
        • Rekruttering
        • Research Site
      • Floridablanca, Colombia, 680001
        • Rekruttering
        • Research Site
      • Medellín, Colombia, 050034
        • Rekruttering
        • Research Site
      • Valledupar, Colombia, 200001
        • Rekruttering
        • Research Site
      • San José, Costa Rica, 1000
        • Rekruttering
        • Research Site
      • San José, Costa Rica, 10108
        • Rekruttering
        • Research Site
      • San José Capital, Costa Rica, 1000
        • Rekruttering
        • Research Site
      • Santa Ana, Costa Rica, 10903
        • Rekruttering
        • Research Site
    • California
      • La Mesa, California, Forente stater, 91942
        • Har ikke rekruttert ennå
        • Research Site
      • Los Alamitos, California, Forente stater, 90720
        • Har ikke rekruttert ennå
        • Research Site
    • Delaware
      • Newark, Delaware, Forente stater, 19713
        • Rekruttering
        • Research Site
    • Florida
      • Bay Pines, Florida, Forente stater, 33744
        • Rekruttering
        • Research Site
      • Clearwater, Florida, Forente stater, 33756
        • Rekruttering
        • Research Site
      • Gainesville, Florida, Forente stater, 32610
        • Rekruttering
        • Research Site
      • St. Petersburg, Florida, Forente stater, 33705
        • Rekruttering
        • Research Site
    • Georgia
      • Marietta, Georgia, Forente stater, 30060
        • Rekruttering
        • Research Site
    • Illinois
      • Chicago, Illinois, Forente stater, 60612
        • Rekruttering
        • Research Site
      • Decatur, Illinois, Forente stater, 62526
        • Rekruttering
        • Research Site
    • Iowa
      • Des Moines, Iowa, Forente stater, 50309
        • Rekruttering
        • Research Site
      • Waterloo, Iowa, Forente stater, 50702
        • Har ikke rekruttert ennå
        • Research Site
    • Kansas
      • Leawood, Kansas, Forente stater, 66209
        • Rekruttering
        • Research Site
    • Kentucky
      • Lexington, Kentucky, Forente stater, 40536
        • Har ikke rekruttert ennå
        • Research Site
      • Owensboro, Kentucky, Forente stater, 42303
        • Rekruttering
        • Research Site
    • Maryland
      • Bethesda, Maryland, Forente stater, 20817
        • Rekruttering
        • Research Site
      • Frederick, Maryland, Forente stater, 21702
        • Rekruttering
        • Research Site
      • Silver Spring, Maryland, Forente stater, 20910
        • Rekruttering
        • Research Site
      • Towson, Maryland, Forente stater, 21204
        • Rekruttering
        • Research Site
    • Michigan
      • Saginaw, Michigan, Forente stater, 48602
        • Har ikke rekruttert ennå
        • Research Site
    • Missouri
      • Bridgeton, Missouri, Forente stater, 63044
        • Rekruttering
        • Research Site
    • Nebraska
      • Lincoln, Nebraska, Forente stater, 68506
        • Rekruttering
        • Research Site
    • Nevada
      • Reno, Nevada, Forente stater, 89511
        • Rekruttering
        • Research Site
    • New Jersey
      • Paramus, New Jersey, Forente stater, 07652
        • Har ikke rekruttert ennå
        • Research Site
    • New York
      • Buffalo, New York, Forente stater, 14215
        • Rekruttering
        • Research Site
      • East Syracuse, New York, Forente stater, 13057
        • Rekruttering
        • Research Site
      • Fresh Meadows, New York, Forente stater, 11366
        • Rekruttering
        • Research Site
      • Rochester, New York, Forente stater, 14642
        • Har ikke rekruttert ennå
        • Research Site
      • Westbury, New York, Forente stater, 11590
        • Rekruttering
        • Research Site
    • Ohio
      • Canton, Ohio, Forente stater, 44718
        • Har ikke rekruttert ennå
        • Research Site
    • Pennsylvania
      • Fountain Hill, Pennsylvania, Forente stater, 18015
        • Rekruttering
        • Research Site
      • Kittanning, Pennsylvania, Forente stater, 16201
        • Har ikke rekruttert ennå
        • Research Site
      • Philadelphia, Pennsylvania, Forente stater, 19104
        • Rekruttering
        • Research Site
    • Texas
      • Round Rock, Texas, Forente stater, 78665
        • Har ikke rekruttert ennå
        • Research Site
    • Washington
      • Aberdeen, Washington, Forente stater, 98520
        • Rekruttering
        • Research Site
      • Renton, Washington, Forente stater, 98055
        • Har ikke rekruttert ennå
        • Research Site
    • West Virginia
      • Charleston, West Virginia, Forente stater, 25304
        • Rekruttering
        • Research Site
      • Morgantown, West Virginia, Forente stater, 26506
        • Rekruttering
        • Research Site
    • Wisconsin
      • Schofield, Wisconsin, Forente stater, 54476
        • Har ikke rekruttert ennå
        • Research Site
      • Angers, Frankrike, 49100
        • Har ikke rekruttert ennå
        • Research Site
      • Avignon, Frankrike, 84000
        • Rekruttering
        • Research Site
      • Boulogne-Billancourt, Frankrike, 92100
        • Rekruttering
        • Research Site
      • Caen, Frankrike, 14000
        • Rekruttering
        • Research Site
      • Chambéry, Frankrike, 73011
        • Rekruttering
        • Research Site
      • Dijon, Frankrike, 21000
        • Rekruttering
        • Research Site
      • La Tronche, Frankrike, 38700
        • Rekruttering
        • Research Site
      • Limoges, Frankrike, 87042
        • Rekruttering
        • Research Site
      • Nantes, Frankrike, 44093
        • Rekruttering
        • Research Site
      • Paris, Frankrike, 75020
        • Rekruttering
        • Research Site
      • Pau, Frankrike, 64046
        • Rekruttering
        • Research Site
      • St-Malo, Frankrike, 35403
        • Rekruttering
        • Research Site
      • Toulouse, Frankrike, 31300
        • Har ikke rekruttert ennå
        • Research Site
      • Tours, Frankrike, 37000
        • Rekruttering
        • Research Site
      • Tbilisi, Georgia, 0159
        • Rekruttering
        • Research Site
      • Tbilisi, Georgia, 0112
        • Rekruttering
        • Research Site
      • Tbilisi, Georgia, 160
        • Rekruttering
        • Research Site
      • Tbilisi, Georgia, 177
        • Rekruttering
        • Research Site
      • Athens, Hellas, 12462
        • Rekruttering
        • Research Site
      • Athens, Hellas, 11527
        • Rekruttering
        • Research Site
      • Athens, Hellas, 115 27
        • Rekruttering
        • Research Site
      • Larissa, Hellas, 411 10
        • Rekruttering
        • Research Site
      • Piraeus, Hellas, 185 37
        • Rekruttering
        • Research Site
      • Piraeus, Hellas, 185 47
        • Rekruttering
        • Research Site
      • Thessaloniki, Hellas, 56429
        • Rekruttering
        • Research Site
      • Thessaloniki, Hellas, 57001
        • Rekruttering
        • Research Site
      • Thessaloniki, Hellas, 55236
        • Rekruttering
        • Research Site
      • Cork, Irland, T12 DFK4
        • Har ikke rekruttert ennå
        • Research Site
      • Dublin, Irland, D08 NHY1
        • Rekruttering
        • Research Site
      • Dublin, Irland, D24 NR0A
        • Rekruttering
        • Research Site
      • Dublin, Irland, D07 R2WY
        • Rekruttering
        • Research Site
      • Dublin, Irland, D09 V2N0
        • Rekruttering
        • Research Site
      • Dublin, Irland, DO4YN63
        • Rekruttering
        • Research Site
      • Galway, Irland, H91 YR71
        • Har ikke rekruttert ennå
        • Research Site
      • Afula, Israel, 1834111
        • Rekruttering
        • Research Site
      • Beersheba, Israel, 8410101
        • Rekruttering
        • Research Site
      • Hadera, Israel, 38100
        • Rekruttering
        • Research Site
      • Haifa, Israel, 34362
        • Rekruttering
        • Research Site
      • Haifa, Israel, 91096
        • Rekruttering
        • Research Site
      • Jerusalem, Israel, 91031
        • Rekruttering
        • Research Site
      • Jerusalem, Israel, 91120
        • Rekruttering
        • Research Site
      • Ramat Gan, Israel, 52621
        • Rekruttering
        • Research Site
      • Tel Aviv, Israel, 64239
        • Rekruttering
        • Research Site
      • Tel Aviv, Israel, 69710
        • Rekruttering
        • Research Site
      • Candiolo, Italia, 10060
        • Rekruttering
        • Research Site
      • Lecco, Italia, 23900
        • Rekruttering
        • Research Site
      • Lucca, Italia, 55100
        • Rekruttering
        • Research Site
      • Meldola, Italia, 47014
        • Rekruttering
        • Research Site
      • Milan, Italia, 20132
        • Rekruttering
        • Research Site
      • Milan, Italia, 20133
        • Har ikke rekruttert ennå
        • Research Site
      • Naples, Italia, 80131
        • Rekruttering
        • Research Site
      • Peschiera del Garda, Italia, 37019
        • Rekruttering
        • Research Site
      • Pisa, Italia, 56126
        • Rekruttering
        • Research Site
      • Roma, Italia, 00144
        • Rekruttering
        • Research Site
      • Torrette Di Ancona, Italia, 60126
        • Rekruttering
        • Research Site
      • Udine, Italia, 33100
        • Rekruttering
        • Research Site
      • Verona, Italia, 37126
        • Rekruttering
        • Research Site
      • Akashi, Japan, 673-8558
        • Rekruttering
        • Research Site
      • Bunkyō City, Japan, 113-8603
        • Rekruttering
        • Research Site
      • Bunkyō City, Japan, 113-8677
        • Rekruttering
        • Research Site
      • Fukuoka, Japan, 812-8582
        • Rekruttering
        • Research Site
      • Fukuoka, Japan, 811-1395
        • Rekruttering
        • Research Site
      • Hamamatsu, Japan, 431-3192
        • Rekruttering
        • Research Site
      • Iwakuni-shi, Japan, 740-8510
        • Rekruttering
        • Research Site
      • Izumi-shi, Japan, 594-0073
        • Rekruttering
        • Research Site
      • Kashihara-shi, Japan, 634-8522
        • Rekruttering
        • Research Site
      • Kobe, Japan, 650-0046
        • Rekruttering
        • Research Site
      • Kurume-shi, Japan, 830-0011
        • Rekruttering
        • Research Site
      • Kyoto, Japan, 602-8566
        • Rekruttering
        • Research Site
      • Kōtoku, Japan, 135-8550
        • Rekruttering
        • Research Site
      • Matsuyama, Japan, 791-0280
        • Rekruttering
        • Research Site
      • Nankoku-shi, Japan, 783-8505
        • Rekruttering
        • Research Site
      • Niigata, Japan, 951-8566
        • Rekruttering
        • Research Site
      • Osaka, Japan, 534-0021
        • Rekruttering
        • Research Site
      • Sakaishi, Japan, 591-8555
        • Rekruttering
        • Research Site
      • Sayama, Japan, 589-8511
        • Rekruttering
        • Research Site
      • Sendai, Japan, 980-0873
        • Rekruttering
        • Research Site
      • Shinagawa-ku, Japan, 142-8666
        • Rekruttering
        • Research Site
      • Takarazuka-shi, Japan, 665-0827
        • Rekruttering
        • Research Site
      • Toon-Shi, Japan, 791-0295
        • Rekruttering
        • Research Site
      • Toyoake-shi, Japan, 470-1192
        • Rekruttering
        • Research Site
      • Toyonaka-shi, Japan, 560-8552
        • Rekruttering
        • Research Site
      • Baoding, Kina, 071000
        • Har ikke rekruttert ennå
        • Research Site
      • Beijing, Kina, 100142
        • Har ikke rekruttert ennå
        • Research Site
      • Beijing, Kina, 100021
        • Rekruttering
        • Research Site
      • Beijing, Kina, 101149
        • Har ikke rekruttert ennå
        • Research Site
      • Bengbu, Kina, 233004
        • Rekruttering
        • Research Site
      • Changchun, Kina, 130000
        • Har ikke rekruttert ennå
        • Research Site
      • Changchun, Kina, 130033
        • Rekruttering
        • Research Site
      • Changsha, Kina, 410013
        • Har ikke rekruttert ennå
        • Research Site
      • Changsha, Kina, 410008
        • Har ikke rekruttert ennå
        • Research Site
      • Chengdu, Kina, 610041
        • Rekruttering
        • Research Site
      • Chongqing, Kina, 400042
        • Har ikke rekruttert ennå
        • Research Site
      • Chongqing, Kina, 400030
        • Har ikke rekruttert ennå
        • Research Site
      • Fuzhou, Kina, 350001
        • Rekruttering
        • Research Site
      • Fuzhou, Kina, 350014
        • Har ikke rekruttert ennå
        • Research Site
      • Guangzhou, Kina, 510080
        • Rekruttering
        • Research Site
      • Haerbin, Kina, 150081
        • Rekruttering
        • Research Site
      • Hangzhou, Kina, 310022
        • Har ikke rekruttert ennå
        • Research Site
      • Hefei, Kina, 133500
        • Rekruttering
        • Research Site
      • Hefei, Kina, 230022
        • Rekruttering
        • Research Site
      • Jiamusi, Kina, 154007
        • Rekruttering
        • Research Site
      • Jinan, Kina, 250117
        • Rekruttering
        • Research Site
      • Langfang, Kina, 65699
        • Rekruttering
        • Research Site
      • Lanzhou, Kina, 730050
        • Rekruttering
        • Research Site
      • Linyi, Kina, 276001
        • Rekruttering
        • Research Site
      • Liuzhou, Kina, 545007
        • Rekruttering
        • Research Site
      • Nanchang, Kina, 330006
        • Rekruttering
        • Research Site
      • Nanchang, Kina, 330029
        • Rekruttering
        • Research Site
      • Nanjing, Kina, 210008
        • Rekruttering
        • Research Site
      • Nanjing, Kina, 210006
        • Rekruttering
        • Research Site
      • Nanning, Kina, 530021
        • Rekruttering
        • Research Site
      • Ningbo, Kina, 315010
        • Rekruttering
        • Research Site
      • Qingdao, Kina, 266071
        • Rekruttering
        • Research Site
      • Shanghai, Kina, 200092
        • Har ikke rekruttert ennå
        • Research Site
      • Shenyang, Kina, 110042
        • Har ikke rekruttert ennå
        • Research Site
      • Shenzhen, Kina, 518116
        • Har ikke rekruttert ennå
        • Research Site
      • Suzhou, Kina, 215004
        • Rekruttering
        • Research Site
      • Taiyuan, Kina, 030000
        • Rekruttering
        • Research Site
      • Wuhan, Kina, 430060
        • Har ikke rekruttert ennå
        • Research Site
      • Wuhan, Kina, 430030
        • Har ikke rekruttert ennå
        • Research Site
      • Xuzhou, Kina, 221002
        • Rekruttering
        • Research Site
      • Yantai, Kina, 264000
        • Rekruttering
        • Research Site
      • Zhengzhou, Kina, 450008
        • Har ikke rekruttert ennå
        • Research Site
      • George Town, Malaysia, 10350
        • Rekruttering
        • Research Site
      • Kota Bharu, Malaysia, 15586
        • Rekruttering
        • Research Site
      • Kuala Lumpur, Malaysia, 50586
        • Rekruttering
        • Research Site
      • Kuala Selangor, Malaysia, 62250
        • Rekruttering
        • Research Site
      • Perai, Malaysia, 13700
        • Rekruttering
        • Research Site
      • Alcabideche, Portugal, 2755-009
        • Rekruttering
        • Research Site
      • Braga, Portugal, 4710-243
        • Rekruttering
        • Research Site
      • Coimbra, Portugal, 3000-075
        • Rekruttering
        • Research Site
      • Lisbon, Portugal, 1400-038
        • Rekruttering
        • Research Site
      • Lisbon, Portugal, 1500-650
        • Rekruttering
        • Research Site
      • Lisbon, Portugal, 1769-001
        • Rekruttering
        • Research Site
      • Loures, Portugal, 2674-514
        • Rekruttering
        • Research Site
      • Matosinhos Municipality, Portugal, 4454-509
        • Rekruttering
        • Research Site
      • Porto, Portugal, 4200-319
        • Rekruttering
        • Research Site
      • Porto, Portugal, 4200-072
        • Rekruttering
        • Research Site
      • Porto, Portugal, 4100-180
        • Rekruttering
        • Research Site
      • Bucharest, Romania, 022328
        • Rekruttering
        • Research Site
      • Bucharest, Romania, 013812
        • Rekruttering
        • Research Site
      • Bucharest, Romania, 30167
        • Rekruttering
        • Research Site
      • Bucharest, Romania, 010626
        • Rekruttering
        • Research Site
      • Craiova, Romania, 200385
        • Rekruttering
        • Research Site
      • Craiova, Romania, 200542
        • Rekruttering
        • Research Site
      • Iași, Romania, 700106
        • Har ikke rekruttert ennå
        • Research Site
      • Otopeni, Romania, 075100
        • Rekruttering
        • Research Site
      • Piteşti, Romania, 110283
        • Rekruttering
        • Research Site
      • Sibiu, Romania, 550253
        • Rekruttering
        • Research Site
      • Timișoara, Romania, 300239
        • Rekruttering
        • Research Site
      • Badajoz, Spania, 06080
        • Rekruttering
        • Research Site
      • Badalona, Spania, 8916
        • Rekruttering
        • Research Site
      • Barcelona, Spania, 08028
        • Rekruttering
        • Research Site
      • Castellon, Spania, 12002
        • Rekruttering
        • Research Site
      • Granada, Spania, 18016
        • Har ikke rekruttert ennå
        • Research Site
      • Jaén, Spania, 23007
        • Har ikke rekruttert ennå
        • Research Site
      • Lugo, Spania, 27003
        • Rekruttering
        • Research Site
      • Madrid, Spania, 28050
        • Har ikke rekruttert ennå
        • Research Site
      • Madrid, Spania, 28040
        • Rekruttering
        • Research Site
      • Madrid, Spania, 28041
        • Har ikke rekruttert ennå
        • Research Site
      • Málaga, Spania, 29010
        • Rekruttering
        • Research Site
      • Oviedo, Spania, 33006
        • Rekruttering
        • Research Site
      • Palma de Mallorca, Spania, 07198
        • Rekruttering
        • Research Site
      • Valencia, Spania, 46015
        • Rekruttering
        • Research Site
      • Vigo (Pontevedra), Spania, 36312
        • Rekruttering
        • Research Site
      • Zaragoza, Spania, 50009
        • Rekruttering
        • Research Site
      • Blackpool, Storbritannia, FY3 8NR
        • Rekruttering
        • Research Site
      • Glasgow, Storbritannia, G12 0YN
        • Rekruttering
        • Research Site
      • Guildford, Storbritannia, GU2 7XX
        • Rekruttering
        • Research Site
      • Hull, Storbritannia, HU16 5JQ
        • Rekruttering
        • Research Site
      • Northwood, Storbritannia, HA6 2RN
        • Rekruttering
        • Research Site
      • Oxford, Storbritannia, OX4 6LB
        • Rekruttering
        • Research Site
      • Lausanne, Sveits, 1011
        • Rekruttering
        • Research Site
      • Jinju, Sør -Korea, 52727
        • Rekruttering
        • Research Site
      • Seoul, Sør -Korea, 5505
        • Rekruttering
        • Research Site
      • Seoul, Sør -Korea, 135-710
        • Rekruttering
        • Research Site
      • Ankara, Tyrkia (Türkiye), 06010
        • Rekruttering
        • Research Site
      • Bakırköy, Tyrkia (Türkiye), 34147
        • Rekruttering
        • Research Site
      • Küçükçekmece, Tyrkia (Türkiye), 34295
        • Rekruttering
        • Research Site
      • Yüreğir, Tyrkia (Türkiye), 01240
        • Rekruttering
        • Research Site
      • Çankaya, Tyrkia (Türkiye), 06680
        • Rekruttering
        • Research Site
      • İzmit, Tyrkia (Türkiye), 41380
        • Rekruttering
        • Research Site
      • Amberg, Tyskland, 92224
        • Rekruttering
        • Research Site
      • Augsburg, by, Tyskland, 86156
        • Har ikke rekruttert ennå
        • Research Site
      • Bad Saarow, Tyskland, 15526
        • Rekruttering
        • Research Site
      • Berlin, Tyskland, 12351
        • Rekruttering
        • Research Site
      • Berlin, Tyskland, 13359
        • Rekruttering
        • Research Site
      • Bonn, Tyskland, 53127
        • Rekruttering
        • Research Site
      • Braunschweig, Tyskland, 38114
        • Rekruttering
        • Research Site
      • Essen, Tyskland, 45147
        • Rekruttering
        • Research Site
      • Flensburg, Tyskland, 24939
        • Rekruttering
        • Research Site
      • Frankfurt am Main, Tyskland, 60431
        • Har ikke rekruttert ennå
        • Research Site
      • Hamburg, Tyskland, 21075
        • Rekruttering
        • Research Site
      • Heidelberg, Tyskland, 69126
        • Rekruttering
        • Research Site
      • Heilbronn, Tyskland, 74078
        • Har ikke rekruttert ennå
        • Research Site
      • Immenhausen, Tyskland, 34376
        • Rekruttering
        • Research Site
      • Koblenz, Tyskland, 56073
        • Rekruttering
        • Research Site
      • Leipzig, Tyskland, 04103
        • Har ikke rekruttert ennå
        • Research Site
      • München, Tyskland, 80336
        • Har ikke rekruttert ennå
        • Research Site
      • Neuss, Tyskland, 41462
        • Har ikke rekruttert ennå
        • Research Site
      • Offenbach, Tyskland, 63069
        • Har ikke rekruttert ennå
        • Research Site
      • Oldenburg, Tyskland, 26121
        • Rekruttering
        • Research Site
      • Remscheid, Tyskland, 42859
        • Har ikke rekruttert ennå
        • Research Site
      • Rotenburg (Wümme), Tyskland, 27356
        • Har ikke rekruttert ennå
        • Research Site
      • Schweinfurt, Tyskland, 97421
        • Rekruttering
        • Research Site
      • Trier, Tyskland, 54292
        • Har ikke rekruttert ennå
        • Research Site
      • Velbert, Tyskland, 42551
        • Rekruttering
        • Research Site
      • Wuppertal, Tyskland, 42283
        • Rekruttering
        • Research Site
      • Würselen, Tyskland, 52146
        • Har ikke rekruttert ennå
        • Research Site
      • Würzburg, Tyskland, 97080
        • Rekruttering
        • Research Site

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Histologically or cytologically documented NSCLC (non small lung cancer), including all histological subtypes.
  • Stage IV mNSCLC (metastatic non-small cell lung cancer) (based on the American Joint Committee on Cancer Edition 8) not amenable to curative treatment.
  • Absence of sensitizing EGFR (epidermal growth factor) mutations and ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) rearrangements. Negative assay result is required for all non-squamous histology subtypes.
  • Absence of documented tumor genomic mutation results from tests conducted as part of standard local practice in any other actionable driver oncogenes for which there are locally approved targeted 1L (first line) therapies.
  • WHO (World Health Organization)/ECOG (Eastern Cooperative Oncology Group) performance status of 0 or 1, with no deterioration over the previous 2 weeks prior to baseline at screening and prior to randomization.
  • Minimum life expectancy of 12 weeks.
  • Provision of acceptable tumor sample for the central testing prior to randomization.
  • At least one lesion not previously irradiated that qualifies as a RECIST 1.1 (Response Evaluation Criteria in Solid Tumors, Version 1.1) TL (target lesion) at baseline and can be accurately measured at baseline as ≥ 10 mm in the longest diameter (except lymph nodes, which must have short axis ≥ 15 mm) with CT (computed tomography) or MRI (magnetic resonance imaging) and is suitable for accurate repeated measurements.
  • Adequate organ and bone marrow function

Exclusion Criteria:

  • As judged by the investigator, any severe or uncontrolled systemic diseases, makes it undesirable for the participant to participate in the study or that would jeopardize compliance with the protocol.
  • History of organ transplant.
  • Active or prior documented autoimmune or inflammatory disorders requiring chronic treatment with steroids or other immunosuppressive treatment.
  • History of another primary malignancy except for malignancy treated with curative intent with no known active disease ≥ 2 years before the first dose of study intervention and of low potential risk for recurrence.
  • Presence of small cell and neuroendocrine histology components.
  • Brain metastases unless asymptomatic, stable, and not requiring steroids or anticonvulsants for at least 4 weeks prior to start of study intervention.
  • Active primary immunodeficiency/active infectious disease(s)
  • Active tuberculosis infection
  • Any prior systemic therapy received for advanced or mNSCLC (metastatic non-small cell lung cancer).
  • Any prior exposure to an anti-TIGIT (T-cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain) therapy or any other anticancer therapy targeting immune-regulatory receptors or mechanisms.
  • Any prior treatment with an anti-PD-1 (programmed cell death protein 1) or anti-PD-L1 (anti-programmed death-ligand 1) agent.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Firemannsrom

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Arm A

Drug: rilvegostomig

Administered intravenously (IV) on Day 1 of each 21-day cycle

Andre navn:
  • AZD2936
Aktiv komparator: Arm B

Drug: Pembrolizumab

Administered intravenously (IV) on Day 1 of each 21-day cycle

Andre navn:
  • KEYTRUDA

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Overall Survival (OS)
Tidsramme: Up to approximately 5 years

OS is defined as the time from randomization until the date of death due to any cause.

Up to approximately 5 years
Progression-Free Survival (PFS)
Tidsramme: Up to approximately 5 years

PFS is defined as the time from randomization until radiological progression per RECIST 1.1 or death due to any cause (in the absence of progression).

Up to approximately 5 years

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Landmark Overall Survival (OS) rates
Tidsramme: Up to approximately 5 years

OS is defined as the time from randomization until the date of death due to any cause.

Up to approximately 5 years
Landmark Progression-Free Survival (PFS) rates
Tidsramme: Up to approximately 5 years

PFS is defined as the time from randomization until radiological progression per RECIST 1.1 or death due to any cause (in the absence of progression).

Up to approximately 5 years
Objective Response Rate (ORR)
Tidsramme: Up to approximately 5 years

ORR is defined as the proportion of participants who have a confirmed CR or confirmed PR, using RECIST 1.1.

Up to approximately 5 years
Duration of Response (DoR)
Tidsramme: Up to approximately 5 years

DoR is defined as the time from the date of first documented response until the date of documented progression using RECIST 1.1 or death due to any cause (in the absence of progression).

Up to approximately 5 years
Time to second progression or death (PFS2)
Tidsramme: Up to approximately 5 years

PFS2 is defined as the time from randomization until the earliest of the progression event (following the initial investigator-assessed progression event), after the start of the first subsequent therapy, or death from any cause, whichever occurs first.

Up to approximately 5 years
Pharmakokinetics (PK) of rilvegostomig
Tidsramme: Up to approximately 5 years

Concentration of rilvegostomig in serum

Up to approximately 5 years
Immunogenicity of rilvegostomig
Tidsramme: Up to approximately 5 years

Presence of antidrug antibodies (ADAs), titer, and neutralizing antibodies for rilvegostomig.

Up to approximately 5 years
Patient-reported physical functioning
Tidsramme: Up to approximately 5 years

Proportion of participants with maintained or improved physical functioning as measured by Patient-Reported Outcomes Measurement Information System Physical Function - Short Form 8c - 7 day (PROMIS PF-SF 8c - 7 day) at each time point.

Up to approximately 5 years
Patient-reported global health status (GHS)/quality of life (QoL)
Tidsramme: Up to approximately 5 years

Time to deterioration (TTD) of GHS/QoL as measured by the European Organization for Research and Treatment of Cancer Item Library 172 (EORTC IL172). TTD is defined as time from randomization to the date of first deterioration.

Up to approximately 5 years
Patient-reported lung cancer symptoms of non-small cell lung cancer (NSCLC)
Tidsramme: Up to approximately 5 years

Time to deterioration (TTD) in pulmonary symptoms as measured by the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ).

TTD is defined as time from randomization to the date of first deterioration.

Up to approximately 5 years

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

10. april 2025

Primær fullføring (Antatt)

17. januar 2030

Studiet fullført (Antatt)

2. desember 2030

Datoer for studieregistrering

Først innsendt

7. mars 2025

Først innsendt som oppfylte QC-kriteriene

7. mars 2025

Først lagt ut (Faktiske)

10. mars 2025

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

25. september 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

24. september 2026

Sist bekreftet

1. september 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-planbeskrivelse

Qualified researchers can request access to anonymized individual participant-level data from AstraZeneca group of companies sponsored clinical trials via the request portal. All requests will be evaluated as per the AZ disclosure commitment:

https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.

Yes, indicates that AZ are accepting requests for IPD, but this does not mean all requests will be shared.

IPD-delingstidsramme

AstraZeneca will meet or exceed data availability as per the commitments made to the EFPIA Pharma Data Sharing Principles. For details of our timelines, please refer to our disclosure commitment at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.

Tilgangskriterier for IPD-deling

When a request has been approved AstraZeneca will provide access to the anonymized individual patient-level data via secure research environment Vivli.org. A Signed Data Usage Agreement (non-negotiable contract for data accessors) must be in place before accessing requested information.

IPD-deling Støtteinformasjonstype

  • STUDY_PROTOCOL
  • SEVJE

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Ja

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere